Danaher Corporation vs Quantum Computing Inc — how do they compare? Danaher Corporation trades at $219.58 (market cap $152.87B), while Quantum Computing Inc trades at $7.39 (market cap $1.69B). The key difference: Danaher Corporation is far larger — about 90.5× Quantum Computing Inc's market cap, and Danaher Corporation pays a 0.74% dividend while Quantum Computing Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Quantum Computing Inc for 25 Days on average.
| DHR | QUBT | |
|---|---|---|
Market Cap | $152.87B | $1.69B |
Volume | 5,228,698 | 7,991,522 |
Sector | Health | Technology |
52-Week High | $242.05 | $21.78 |
52-Week Low | $161.91 | $6.31 |
Typical Hold Time | 69 Days | 25 Days |
Enterprise Value | $175.08B | $753.24M |
Dividend Yield | 0.74% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.
The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.
QUBT trades at $7.39, down 3.02% today, amid a bearish technical signal from moving averages but bullish oscillators. The company reported Q2 2026 revenue of $5.6 million (Zacks Investment Research, 2026-09-08) but remains unprofitable with a net income margin of -152.45%. Recent news highlights the launch of Dirac-3S, scaling to 10,000 variables, with first shipments expected in Q4 2026 (PRNewsWire, 2026-10-01).
Analyst consensus is bullish with a $17.33 price target, but the stock faces significant risks from persistent losses, high cash burn, and competitive pressures. Investment appeal hinges on successful commercialization of quantum technology, though profitability remains distant. The company's $42.5 million backlog and liquidity provide some cushion against execution risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.
Read more on QUBT →